StrokeNCT06996769
Constraint-Induced Movement Therapy After Stroke
A study testing constraint induced therapy and Conventional therapy for stroke patient in people with Stroke and Hemiplegia Following Ischemic Stroke, run by Hanan Hosny M Battesha at 1 site in Jordan.
Trial summary
Constraint-induced movement therapy (CIMT) is a neurological rehabilitation treatment designed to improve upper and lower extremities motor functions after stroke. The basis of CIMT is improving the function of the affected limb after a stroke by restricting the use of the healthy limb and forcing the use of the… Read more about this study
- Who is it for?
- Ages 50 to 65 years
- Conditions the study is for
- Stroke, Hemiplegia Following Ischemic Stroke
- What is being tested?
- constraint induced therapy and Conventional therapy for stroke patient
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteJordan
- Study dates
- 1 Jun 2025to 20 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- grade 1 or 1+ modified ashower scale
- Walk independently
Who cannot join
- moderate to sever spasticity
- balance dysfunction
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Constrain Induced Therapy to Improve Motor Function and Body Balance in Patients With Stroke
Constraint-induced movement therapy (CIMT) is a neurological rehabilitation treatment designed to improve upper and lower extremities motor functions after stroke. The basis of CIMT is improving the function of the affected limb after a stroke by restricting the use of the healthy limb and forcing the use of the affected side. The core strategy of CIMT is the application of movement techniques, behavioral techniques and restriction methods to increase the frequency of use of the affected limb in stroke patients, improve the quality of movement of the affected limb in real-life scenarios, prevent or correct the learned non-use of the affected limb, and promote the recovery of motor function in the affected limb. This method induces the use of the affected limb, corrects or reverses habitual disuse and neglect of the affected limb, and provides structural and functional training and repeated practice opportunities for the affected limb.
- Conditions
- Stroke, Hemiplegia Following Ischemic Stroke
- Being tested
- constraint induced therapy, Conventional therapy for stroke patient
- Keywords
- Constraint-Induced Movement, stroke, motor function, body balance
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
constraint induced therapyOther
Constraint induced movement therapy (CIMT) is a treatment approach that can be used with patients who have had a CVA. In order to be eligible for the therapy, the clients must have at least 10 degrees of active wrist and finger extension. During this treatment the unaffected limb is restrained (usually with a sling or a mitt) for 90% of their waking hours. This treatment forces the client to use the affected limb throughout their daily tasks in order to combat learned non-use of the affected limb.
Conventional therapy for stroke patientOther
general exercises
| Study group | Role | What they receive |
|---|---|---|
| control group | Active comparator | Not described Receives: Other: Conventional therapy for stroke patient |
| intervention | Experimental | intervenstion study Receives: Other: constraint induced therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
motor function
scale to measure activity of daily lining of upper limb and lower limb and trunk control; when the number of scores increases, that means patient better
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 May 2025
- Study start1 Jun 2025
- Primary completion15 Jul 2025
- Study completion20 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hanan Hosny M Battesha
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Hanan Hosny M Battesha, Al-Zaytoonah University of Jordan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06996769
- Sponsor's protocol ID
- STROKE
- Status last verified
- Aug 2025
- First submitted
- 4 May 2025
- Last updated
- 22 Aug 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Constrain Induced Therapy to Improve Motor Function and Body Balance in Patients With Stroke
- ClinicalTrials.gov ID
- NCT06996769
- Acronym / sponsor ID
- STROKE
- Conditions
- Stroke, Hemiplegia Following Ischemic Stroke
- Keywords
- Constraint-Induced Movement, stroke, motor function, body balance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Hanan Hosny M BatteshaUniversity, hospital or other
- Study start
- 1 Jun 2025 (actual)
- Primary completion
- 15 Jul 2025 (actual)
- Study completion
- 20 Aug 2025 (actual)
- First posted
- 30 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Constraint-induced movement therapy (CIMT) is a neurological rehabilitation treatment designed to improve upper and lower extremities motor functions after stroke. The basis of CIMT is improving the function of the affected limb after a stroke by restricting the use of the healthy limb and forcing the use of the affected side. The core strategy of CIMT is the application of movement techniques, behavioral techniques and restriction methods to increase the frequency of use of the affected limb in stroke patients, improve the quality of movement of the affected limb in real-life scenarios, prevent or correct the learned non-use of the affected limb, and promote the recovery of motor function in the affected limb. This method induces the use of the affected limb, corrects or reverses habitual disuse and neglect of the affected limb, and provides structural and functional training and repeated practice opportunities for the affected limb.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| control group | Active comparator | Other: Conventional therapy for stroke patient |
| intervention | Experimental | Other: constraint induced therapyintervenstion study |
Who may qualify
- Ages
- 50 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- grade 1 or 1+ modified ashower scale
- Walk independently
Key exclusion criteria (2 listed)
- moderate to sever spasticity
- balance dysfunction
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| constraint induced therapyConstraint induced movement therapy (CIMT) is a treatment approach that can be used with patients who have had a CVA. In order to be eligible for the therapy, the clients must have at least 10 degrees of active wrist and finger extension. During this treatment the unaffected limb is restrained (usually with a sling or a mitt) for 90% of their waking hours. This treatment forces the client to use the affected limb throughout their daily tasks in order to combat learned non-use of the affected limb. | Other | intervention |
| Conventional therapy for stroke patientgeneral exercises | Other | control group |
Primary outcome
motor function
Time frame: 4 weeks
scale to measure activity of daily lining of upper limb and lower limb and trunk control; when the number of scores increases, that means patient better
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Aug 2025.
Related trials for Stroke
Not yet recruiting
Closed-Loop SCS-BCI for Post-Stroke Hemiplegia
Stroke, Motor Dysfunction
Active, not recruiting
Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke
Stroke, Cognitive Dysfunction
Not yet recruitingObservational study
A Speaking-Valve-Based Decannulation Protocol for Tracheostomized Stroke Patients
Stroke Patients, Tracheostomy
RecruitingPhase 4
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
Cerebrovascular Disorders
Not yet recruiting
Effect of Early Tendon Vibrations on Upper Limb Motor Recovery After a Stroke
Acute Stroke, Upper Limb Motor Deficit
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing constraint induced therapy and Conventional therapy for stroke patient in people with Stroke and Hemiplegia Following Ischemic Stroke, run by Hanan Hosny M Battesha at 1 site in Jordan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
motor function (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2025.